Walleye Capital’s Sensus Healthcare SRTS Stock Holding History

Walleye Capital’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-31,000	Closed	-$230K	–	4335
2022 Q4	$230K	Buy	+31,000	New	+$280K	﹤0.01%	1946

Other funds holding SRTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Walleye Capital's SRTS Position: Q1 2023 in Review

Walleye Capital sold out of Sensus Healthcare (SRTS) in Q1 2023, closing a stake of 31,000 shares — an estimated $230K sold.

Walleye Capital first reported a position in SRTS in Q4 2022 and held it in 1 quarter. The position peaked at $230K in Q4 2022. 67 funds tracked by Wall St. Rank hold SRTS as of Q1 2023.

Walleye Capital reported no remaining Sensus Healthcare position as of Q1 2023 after selling out during the quarter.
Walleye Capital sold 31,000 Sensus Healthcare shares in Q1 2023, an estimated $230K.
Walleye Capital first reported a position in Sensus Healthcare in Q4 2022 and held it in 1 quarter.
Walleye Capital's Sensus Healthcare position peaked at $230K in Q4 2022.
67 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.